Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease.
Saved in:
| Title: | Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease. |
|---|---|
| Authors: | Roden RT; Mayo Clinic Alix School of Medicine, Rochester, MN, USA., Harmsen WS; Mayo Clinic Department of Biostatistics and Health Sciences Research, Rochester, MN, USA., Breen WG; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Moffett JN; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Pulsipher SD; Mayo Clinic Department of Biostatistics and Health Sciences Research, Rochester, MN, USA., Olivier KR; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Garces YI; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Park SS; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Merrell KW; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Sarkaria JN; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Owen D; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA. Electronic address: Owen.Dawn@mayo.edu. |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Nov; Vol. 209, pp. 108789. Date of Electronic Publication: 2025 Oct 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
